Tag: American Venous Forum

Select gene single nucleotide polymorphisms found to be associated with venous...

Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...

AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”

An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...

AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...

Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...
Fedor Lurie

2020 update to CEAP classification system and reporting standards published

A 2020 update on the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system and reporting standards, authored by Fedor Lurie (Jobst Vascular Institute, Toledo, USA; University of Michigan,...

AVF releases white paper on considerations in prophylaxis and treatment of...

The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...

Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness

As a podium talk at the annual meeting of the American Venous Forum (VENOUS 2020; 3–6 March, Amelia Island, USA), it represented a bit...